These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19434920

  • 1. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B, Gupta V, Ma C, Mahajan N, Akrami A, Surapaneni S.
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [Abstract] [Full Text] [Related]

  • 2. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL, Zanon RL, Alvarez-Nunez F, Munson EJ.
    Mol Pharm; 2013 May 06; 10(5):1949-57. PubMed ID: 23574401
    [Abstract] [Full Text] [Related]

  • 3. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
    Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S.
    J Pharm Sci; 2009 Feb 06; 98(2):516-28. PubMed ID: 18543293
    [Abstract] [Full Text] [Related]

  • 4. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I, Snyder J, Vippagunta R, Alvine M, Vakil R, Tong WQ, Vippagunta S.
    Int J Pharm; 2011 Oct 31; 419(1-2):12-9. PubMed ID: 21782911
    [Abstract] [Full Text] [Related]

  • 5. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD, Ju TC, Lee PI.
    Eur J Pharm Biopharm; 2012 May 31; 81(1):149-58. PubMed ID: 22233548
    [Abstract] [Full Text] [Related]

  • 6. Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor.
    Cui Y, Chiang PC, Choo EF, Boggs J, Rudolph J, Grina J, Wenglowsky S, Ran Y.
    Int J Pharm; 2013 Sep 15; 454(1):241-8. PubMed ID: 23834830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
    Sotthivirat S, McKelvey C, Moser J, Rege B, Xu W, Zhang D.
    Int J Pharm; 2013 Aug 16; 452(1-2):73-81. PubMed ID: 23651642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics.
    Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R, Akrami A, Rose M, Surapaneni S, Bostick T, King A, Neervannan S, Ostovic D, Koparkar A.
    J Pharm Sci; 2008 Sep 16; 97(9):3942-56. PubMed ID: 18214948
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG.
    Int J Pharm; 2010 Aug 16; 395(1-2):161-6. PubMed ID: 20580799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ, Kwon R, Quan QZ, Oh DH, Kim JO, Hwang MR, Koo YB, Woo JS, Yong CS, Choi HG.
    Arch Pharm Res; 2009 May 16; 32(5):767-72. PubMed ID: 19471892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E, Pendela M, Baert L, Rosier J, Van 't Klooster G, De Man H, Bouche MP, Schueller L, Van Remoortere P, Wigerinck P, Adams E, Hoogmartens J, Van den Mooter G.
    Eur J Pharm Biopharm; 2008 Nov 16; 70(3):853-60. PubMed ID: 18657611
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.